Has Mark Blitzer, MD received payments from drug or device companies?

Yes. Drug and device makers reported $5,885 in general payments to Mark Blitzer, MD across 32 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mark Blitzer, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mark Blitzer, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mark Blitzer, MD

Cardiovascular Disease · New Haven, CTNPI 1164428207

Payments from drug & device makers

$5,885in general payments, 2019–2025

Across 32 payments — averaging $183.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$3K
Medtronic$2K
Biosense Webster, Inc.$229
Abbott$103

What the payments were for

Consulting fees$3,43858%
Travel & lodging$72312%
Food & beverage$1,65428%
Education$701%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	4	$3,498
Medtronic(2 entities)	24	$2,055
Biosense Webster, Inc.	3	$229
Abbott	1	$103

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,885 in reported general payments places this provider in the 70th percentile of 415 cardiovascular disease providers in Connecticut.

See all cardiovascular disease providers in Connecticut →

Medicare billing

Part B allowed, 2024

$227,267

Medicare patients

1,482

Services billed

4,413

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	342	$463,081
XareltoRivaroxaban	122	$170,547
Flecainide Acetate	191	$10,682
Dofetilide	23	$10,311
Amiodarone Hcl	151	$6,058
Metoprolol Succinate	429	$5,664
Diltiazem 24hr Er (Cd)Diltiazem Hcl	94	$4,614
Mexiletine Hcl	32	$3,740
SotalolSotalol Hcl	91	$2,120
Midodrine Hcl	16	$680
Rosuvastatin Calcium	43	$515
Carvedilol	52	$457
Lisinopril	39	$282
Metoprolol Tartrate	59	$251
Levothyroxine Sodium	14	$249

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in New Haven

Harlan KrumholzNew Haven$4M
Jeffery TestaniNew Haven$3.4M
Nihar DesaiNew Haven$3.2M
John ForrestNew Haven$1.2M
Hyung ChunNew Haven$1.1M
Rohan KheraNew Haven$930K
Carlos Mena-HurtadoNew Haven$665K
John StendahlNew Haven$419K
Tariq AhmadNew Haven$317K
Rachel LampertNew Haven$310K

See the full list for Connecticut →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →